Table 5 Logistic regression analysis was performed to determine the impact of each clinical indicator on efficacy
From: A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Indicators | P-value | OR | 95% interval |
|---|---|---|---|
Age(year) | 0.683 | 0.995 | 0.969–1.021 |
Glandular tissue thickness(mm) | 0.549 | 1.072 | 0.854–1.346 |
Clinical Staging | 0.896 | 1.084 | 0.323–3.633 |
Estrogen level | 0.007 | 1.035 | 1.009–1.061 |
Grouping | 0.000 | 0.097 | 0.043–0.216 |